4,4,5,5-Tetramethyl-2-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,2-dioxaborolane → HCID 22240130, compound

HRID 891936Notes

Reaction equation

HRID 891936 reaction equation
CC1(C)C(C)(C)OB([C:9]2[CH:18]=[CH:17][C:16]3[CH2:15][CH2:14][CH2:13][CH2:12][C:11]=3[CH:10]=2)O1.[Cl:20][C:21]1[CH:22]=[C:23]([CH2:27][N:28]2[CH:32]=[CH:31][N:30]=[C:29]2[CH3:33])[N:24]=[N:25][CH:26]=1>>[ClH:20].[CH3:33][C:29]1[N:28]([CH2:27][C:23]2[N:24]=[N:25][CH:26]=[C:21]([C:9]3[CH:18]=[CH:17][C:16]4[CH2:15][CH2:14][CH2:13][CH2:12][C:11]=4[CH:10]=3)[CH:22]=2)[CH:32]=[CH:31][N:30]=1

Participants

3

Reactant 2

HCID 115362114,4,5,5-Tetramethyl-2-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,2-dioxaborolaneHCID 117890255-Chloro-3-(2-methylimidazol-1-ylmethyl)-pyridazine

Product 1

HCID 22240130HCID 22240130, compound

Procedure

The title compound, MS: m/e=305.3 (M+H+), was prepared from 4,4,5,5-tetramethyl-2-(5,6,7,8-tetrahydro-naphthalen-2-yl)-[1,3,2]dioxaborolane and 5-chloro-3-(2-methyl-imidazol-1-yl-methyl)-pyridazine.

Sources & evidence

ORD record
ord-c834be5c62334df4b95cbfcb36a0392b
Source dataset
uspto-grants-2006_02
Patent number
US07005432B2

Reaction notes

Loading…